Social Media Ideas for Glp-1 News

<![CDATA[Where GLP-1 Development May be Headed]]>

<![CDATA[The Most Surprising Development in GLP-1s]]>

GLP-1s: Still Early In The Growth Story

What can GLP-1s do beside treat diabetes and obesity?

GLP-1 agonists go beyond treating metabolic disease. They have shown promise in treating MASH, addiction, sleep apnea, and neurodegeneration. The post What can GLP-1s do beside tre...

Beyond Ozempic: the GLP-1 landscape in 2026 

There is a lot going on in the GLP-1 space, a market that landed $79 billion last year, and could shift significantly in the coming years. The post Beyond Ozempic: the GLP-1 landsc...

<![CDATA[ESC 2026: GLP-1–Based Therapies Move Further into Mainstream Cardiovascular Care]]>

One specific clinical group sees huge surge in GLP-1 prescriptions

GLP-1 Drugs Linked to Fewer Heart Complications and Infections After Surgery, New Study Finds

A new study of more than 2 million surgical patients found that those taking GLP-1 medications had lower odds of serious heart complications and infections after surgery. The findi...

Are GLP-1s the new statins?

Cardiologists are working the weight-loss drugs into more patient conversations.

GLP-1 Use Surging Among New Mothers

FRIDAY, Oct. 2, 2026 — More women are now being prescribed GLP-1 medications like Ozempic and Zepbound after giving birth. A new study finds GLP-1 use among new mothers jumped from...

Limiting Weight Regain After GLP-1s: Two Strategies Show Promise

WEDNESDAY, Oct. 7, 2026 — What’s the best way to keep the scale from creeping back up after you stop using a GLP-1 medication? A study published today in the journal Obesity Scien...

<![CDATA[How Cortisol-Targeted Approaches Might be Paired with GLP-1 Medications]]>

Are GLP-1s the New Statins?

The drug is already shaping up as a popular alternative.

GLP-1s Show Benefit For Kids With Type 2 Diabetes

FRIDAY, Oct 2, 2026 — A real-world study finds GLP-1 medications helped kids, teens and young adults with type 2 diabetes lose weight, as well as improve their blood pressure and b...

Lilly’s Retatrutide GLP-1 Delivers Average Weight Loss of 50 Pounds

The experimental drug is not FDA-approved, and its biologic classification could shape when lower-cost competitors reach patients if regulators approve it.

Real-world findings suggest GLP-1 drugs offer health benefits for young people with diabetes

New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, from Sept. 28–Oct. 2 examined the real-world use of GLP-1...

GLP 1 reshaping food choices and eating behaviours

IFF has released new research examining how GLP 1 use is influencing food behaviours among Indian consumers and what those shifts may mean for the future of food and beverage innov...

As GLP-1s reshape America, questions and new uses emerge

Hailed by some as miracle drugs, GLP-1s have surged in popularity in the past few years. An estimated one out of every eight Americans is now on some version of them and scientists...

<![CDATA[How a Shift Towards Oral Medications Impacts GLP-1s]]>

Lilly’s GIP/GLP-1 Candidate Brenipatide Shows Early Clinical Promise in Substance, Psych Disorders

Brenipatide showed a mean half-life ranging between 9.08 days and 12.5 days, with the longer half-life seen in participants given the highest dose of the drug at 4.5 mg. The post...

GLP-1 Drugs Take Centre Stage as UK Obesity Congress Reveals New Evidence on Care, Stigma and Scale

New research presented at the 11th UK Congress on Obesity in Sheffield shows GLP-1 medications are reshaping treatment while behavioural support, stigma reduction and system-level...

Finally, Some Evidence Employers Can Use to Justify Covering GLP-1s

Finally, Some Evidence Employers Can Use to Justify Covering GLP-1s Anonymous (not verified) Thu, 08/27/2026 - 09:40 pharmagather item url Finally, Some Ev...

Should you try an off-label GLP-1?

Dr Paul Harris – who heads up the peptide laboratory in the Biology department at Auckland University and spends his life studying and making peptides – has good reason to sound th...

Children Taking GLP-1 Drugs May Face Nutritional Deficiencies, New Study Finds

GLP-1 medications usually make headlines as an adult story. But children are taking them too, prescribed for weight loss, prediabetes, and type 2 diabetes. Now, a new study is look...